
Pharma Marketing Blog represents the opinions of John Mack Publisher of Pharma Marketing News.
We accept advertising relevant to the interests of our members. For more information, see:
Media Kit
Operated by:
VirSci Corporation
PO Box 760
Newtown, PA 18940
215-504-4164
215-504-5739 (FAX)
E-mail: infovirsci@virsci.com
|

My Humble Opinion
|
Other People's Opinion
|
|
A "Must Read" Blog for Insiders. -- Wall Street Journal
|
A bi-weekly podcast. Listen and call-in live online or download to your iPod!
|
| Also see Pharma Marketing News OpEd Pieces |
FDA Won't be Previewing TV DTC Ads!
Posted: January 17, 2008
The FDA has announced in the Federal Register that it was canceling its program to preview broadcast DTC ads submitted to it by the drug industry. This program was inserted in the FDA Amendments Act (FDAAA), but the FDA was not given authority to charge user fees to cover the program over a 5-year period.
To learn more about this and the read the FDA statement, see today's post to Pharma Marketing Blog.
For more posts in related topic areas, see:
If you wish to receive notice by email whenever a post is made to Pharma Marketing Blog, please subscribe.
| Return to Pharma Marketing Blog Topics |
|
Special Supplement
Physician Education
Key Opinion Leaders, Medical Science Liaisons, & CME
It's a new era for pharmaceutical company support of physician education. New guidelines and regulations from various governmental and non-governmental regulatory bodies have come into play during the past few years. The second event defining this new era was the withdrawal of Vioxx from the market in 2004 and the subsequent re-emergence of the importance of physicians as "learned intermediaries."
More than ever, it is important to educate physicians about new drugs and to keep this education separate from the marketing function of the company yet aligned with commercial goals.
This Special Supplement to Pharma Markeing News is critical reading for pharmaceutical companies and physician education service providers wishing to understand the new roles of key opinion leader physicians (KOLs) and medical science liaisons (MSLs) in the physician education process.
TABLE OF CONTENTS
Order and pay for this Special Supplement now using your credit card
ONLY $29.95 PDF file delivered to you by email (usually within minutes of placing your order):
If you wish to pay by check or credit card off-line, please use:
Printable Order Form
|
|